While FDA’s draft guidance may alleviate some of the pressures when biosimilar developers, there are still other significant ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its wholly-owned subsidiary, T-mab, has successfully passed the on-site GMP ...

End-to-end digital twins for continuous automated manufacturing could slash production costs compared to batch manufacturing.

Cancer therapeutics and orphan drugs are no longer niche areas. Specialty drugs are now a significant portion of the ...

The Sam Chun Dang Pharm incident, where the stock price plummeted by half after briefly reaching the top market ...

With this transaction, Biogen now owns exclusive worldwide development and commercialization rights to felzartamab, consolidating global rights ...

The course offers significant market opportunities by equipping senior and project managers with essential FDA-related insights, enhancing team interaction, and streamlining drug application processes ...

This week, PharmTech took a look at the shift toward proactive, data-driven contamination control, the adoption of advanced material science to solve manufacturing hurdles, and an ...

SAN DIEGO, CA / ACCESS Newswire / April 6, 2026 / Bora Biologics today announced the successful completion of its first 2,000-liter engineering, scale up, and process confirmation run at its ...